CBP/p300 bromodomains regulate amyloid-like protein aggregation upon aberrant lysine acetylation
Lysine acetylation is becoming increasingly recognized as a general biological principle in cellular homeostasis, and is subject to abnormal control in different human pathologies. Here, we describe a global effect on amyloid-like protein aggregation in human cells that results from aberrant lysine...
Hlavní autoři: | Olzscha, H, Fedorov, O, Kessler, B, Knapp, S, La Thangue, N |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Cell Press
2016
|
Podobné jednotky
-
Bromodomains control amyloid-like aggregation of aberrantly acetylated proteins
Autor: Olzscha, H, a další
Vydáno: (2018) -
Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
Autor: Popp, T, a další
Vydáno: (2016) -
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
Autor: Hay, D, a další
Vydáno: (2014) -
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Autor: Picaud, S, a další
Vydáno: (2015) -
Targeting bromodomains: epigenetic readers of lysine acetylation.
Autor: Filippakopoulos, P, a další
Vydáno: (2014)